Posted by Lars Charter on Nov 19th, 2024
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) was the target of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 6,910,000 shares, a growth of 6.1%...
More of this article »